EcoDrugPlus

Matrix Metallopeptidase 7

Ensembl ID : ENSDNOG00000007066
Gene Symbol: MMP7
4 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSDNOG00000031096
Gene Symbol: MMP9
4 Cross references
216 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSDNOG00000023681
Gene Symbol: MTOR
2 Cross references
224 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSDNOG00000047411
Gene Symbol: MC1R
2 Cross references
159 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSDNOG00000025087
Gene Symbol: MC3R
4 Cross references
139 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSDNOG00000043358
Gene Symbol: MC4R
4 Cross references
229 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSDNOG00000017178
Gene Symbol: MME
4 Cross references
236 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSDNOG00000009912
Gene Symbol: METAP2
2 Cross references
230 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSDNOG00000008225
Gene Symbol: MAPT
2 Cross references
226 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSDNOG00000002388
Gene Symbol: MAPK10
2 Cross references
222 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSDNOG00000032651
Gene Symbol: MAPK14
4 Cross references
295 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSDNOG00000040002
Gene Symbol: MAPK3
2 Cross references
199 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).